| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.77e-05 | 6 | 194 | 3 | GO:0016421 | |
| GeneOntologyMolecularFunction | biotin binding | 1.77e-05 | 6 | 194 | 3 | GO:0009374 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 3.07e-05 | 7 | 194 | 3 | GO:0016885 | |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 9.39e-05 | 2 | 194 | 2 | GO:0003989 | |
| Domain | - | 6.35e-06 | 13 | 186 | 4 | 3.40.50.20 | |
| Domain | PreATP-grasp_dom | 8.82e-06 | 14 | 186 | 4 | IPR016185 | |
| Domain | Biotin_BS | 9.58e-06 | 5 | 186 | 3 | IPR001882 | |
| Domain | Biotin_COase_C | 9.58e-06 | 5 | 186 | 3 | IPR005482 | |
| Domain | BC | 9.58e-06 | 5 | 186 | 3 | PS50979 | |
| Domain | Biotin_carb_C | 9.58e-06 | 5 | 186 | 3 | SM00878 | |
| Domain | Biotin_carb_C | 9.58e-06 | 5 | 186 | 3 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 9.58e-06 | 5 | 186 | 3 | IPR011764 | |
| Domain | CPSASE_1 | 9.58e-06 | 5 | 186 | 3 | PS00866 | |
| Domain | BIOTIN | 9.58e-06 | 5 | 186 | 3 | PS00188 | |
| Domain | - | 1.19e-05 | 15 | 186 | 4 | 3.30.1490.20 | |
| Domain | Rudment_hybrid_motif | 1.90e-05 | 6 | 186 | 3 | IPR011054 | |
| Domain | CPSASE_2 | 1.90e-05 | 6 | 186 | 3 | PS00867 | |
| Domain | ATP_grasp_subdomain_1 | 2.61e-05 | 18 | 186 | 4 | IPR013815 | |
| Domain | - | 2.61e-05 | 18 | 186 | 4 | 3.30.470.20 | |
| Domain | PRAME_family | 3.28e-05 | 19 | 186 | 4 | IPR026271 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 3.30e-05 | 7 | 186 | 3 | IPR005479 | |
| Domain | BC-like_N | 3.30e-05 | 7 | 186 | 3 | IPR005481 | |
| Domain | CPSase_L_D2 | 3.30e-05 | 7 | 186 | 3 | PF02786 | |
| Domain | Biotin_carb_N | 3.30e-05 | 7 | 186 | 3 | PF00289 | |
| Domain | Biotin_lipoyl | 7.81e-05 | 9 | 186 | 3 | PF00364 | |
| Domain | ACC_central | 9.86e-05 | 2 | 186 | 2 | PF08326 | |
| Domain | AcCoA_COase_cen | 9.86e-05 | 2 | 186 | 2 | IPR013537 | |
| Domain | BIOTINYL_LIPOYL | 1.11e-04 | 10 | 186 | 3 | PS50968 | |
| Domain | Biotin_lipoyl | 1.11e-04 | 10 | 186 | 3 | IPR000089 | |
| Domain | CRAL-bd_toc_tran | 2.00e-04 | 12 | 186 | 3 | IPR001071 | |
| Domain | Single_hybrid_motif | 2.00e-04 | 12 | 186 | 3 | IPR011053 | |
| Domain | CRAL_TRIO_N | 2.00e-04 | 12 | 186 | 3 | SM01100 | |
| Domain | ATP_grasp_subdomain_2 | 2.43e-04 | 31 | 186 | 4 | IPR013816 | |
| Domain | ATP_GRASP | 3.26e-04 | 14 | 186 | 3 | PS50975 | |
| Domain | ATP-grasp | 3.26e-04 | 14 | 186 | 3 | IPR011761 | |
| Domain | CRAL/TRIO_N_dom | 4.05e-04 | 15 | 186 | 3 | IPR011074 | |
| Domain | Pecanex_C | 5.84e-04 | 4 | 186 | 2 | PF05041 | |
| Domain | Carboxyl_trans | 5.84e-04 | 4 | 186 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 5.84e-04 | 4 | 186 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 5.84e-04 | 4 | 186 | 2 | PS50980 | |
| Domain | COA_CT_N | 5.84e-04 | 4 | 186 | 2 | IPR011762 | |
| Domain | COA_CT_C | 5.84e-04 | 4 | 186 | 2 | IPR011763 | |
| Domain | Pecanex | 5.84e-04 | 4 | 186 | 2 | IPR007735 | |
| Domain | Carboxyl_trans | 5.84e-04 | 4 | 186 | 2 | IPR000022 | |
| Domain | GOLD_dom | 8.37e-04 | 19 | 186 | 3 | IPR009038 | |
| Domain | GOLD | 8.37e-04 | 19 | 186 | 3 | PS50866 | |
| Domain | CRAL_TRIO | 1.13e-03 | 21 | 186 | 3 | PF00650 | |
| Domain | SURP | 1.44e-03 | 6 | 186 | 2 | PS50128 | |
| Domain | Surp | 1.44e-03 | 6 | 186 | 2 | PF01805 | |
| Domain | SWAP | 1.44e-03 | 6 | 186 | 2 | SM00648 | |
| Domain | Surp | 1.44e-03 | 6 | 186 | 2 | IPR000061 | |
| Domain | - | 1.49e-03 | 23 | 186 | 3 | 3.40.525.10 | |
| Domain | SEC14 | 1.90e-03 | 25 | 186 | 3 | SM00516 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SF3B4 ACACA DDX1 GAB2 FSIP2 DLC1 MDN1 FAM83G HELZ BICC1 RAP1GAP TCF20 PARP8 SIK3 STIL FRMD6 EIF4G1 GAN SRPK3 LIMCH1 USP54 PARD3 RNF180 | 7.97e-10 | 861 | 196 | 23 | 36931259 |
| Pubmed | ACACA DHX38 STAU1 MDN1 XPO5 ATAD2B HELZ HERC2 PRRC2B FLNC CHERP POLR1A TCF20 U2SURP DIDO1 UPF1 CSE1L EIF4G1 MRTO4 PRKDC | 1.08e-09 | 653 | 196 | 20 | 22586326 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SF3B4 ACACA ACACB DHX38 ADAR HNRNPH2 DDX1 EIF3CL MDN1 XPO5 HELZ DDX39B CHERP POLR1A U2SURP SMPD4 DIDO1 UPF1 TERT RSBN1 EIF4G1 MRTO4 PRKDC LRBA SNRPA PCCA | 3.13e-08 | 1318 | 196 | 26 | 30463901 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | TRIM25 ACACA DDX1 STAU1 MDN1 UFD1 SCN8A UNC79 FLNC UPF1 MYOF CSE1L EIF4G1 DAAM2 PCNX1 PRKDC LRBA PCCA DISP1 DNPEP | 3.73e-08 | 807 | 196 | 20 | 30575818 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FAM120B SF3B4 WDR33 ADAR HNRNPH2 DDX1 STAU1 SYNGAP1 SUN2 DHX35 DDX39B FLNC CHERP TCF20 U2SURP SMPD4 DIDO1 UPF1 SIK3 CSE1L EIF4G1 PRKDC SNRPA | 5.54e-08 | 1082 | 196 | 23 | 38697112 |
| Pubmed | 1.43e-07 | 104 | 196 | 8 | 9205841 | ||
| Pubmed | 1.76e-07 | 3 | 196 | 3 | 22371261 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SF3B4 WDR33 DHX38 ADAR HNRNPH2 DDX1 STAU1 XPO5 HELZ DDX39B PRRC2B RPF1 CHERP U2SURP DIDO1 UPF1 MRTO4 PRKDC SNRPA | 1.83e-07 | 807 | 196 | 19 | 22681889 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FAM120B TRIM25 ACACA UBE4B DHX38 TSC1 ADAR HNRNPH2 DDX1 STAU1 MDN1 UFD1 HERC2 DDX39B FLNC POLR1A TCF20 U2SURP UPF1 CSE1L EIF4G1 MRTO4 PRKDC PARD3 SNRPA | 2.03e-07 | 1353 | 196 | 25 | 29467282 |
| Pubmed | ACACA DHX38 ADAR DDX1 STAU1 CLPB XPO5 UFD1 RPF1 U2SURP UPF1 RSBN1 CSE1L MRTO4 PRKDC SNRPA DNPEP | 2.08e-07 | 653 | 196 | 17 | 33742100 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | TRIM25 ACACA DHX38 ADAR HNRNPH2 STAU1 CLPB DHX35 HERC2 DDX39B POLR1A UPF1 ACTR6 USP54 | 2.39e-07 | 440 | 196 | 14 | 34244565 |
| Pubmed | HDAC9 SF3B4 UBE4B GATM ZNF227 SYNGAP1 CADM1 CLPB PTPRK RNF216 DHX35 TAF1 HERC2 MTUS2 CNTN4 RAP1GAP OXR1 EIF4G1 LRP1 DAAM2 PRKDC USP54 LRBA USPL1 | 3.00e-07 | 1285 | 196 | 24 | 35914814 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SF3B4 UBE4B WDR33 ZNF227 SYNGAP1 CADM1 PTPRK XPO5 SUN2 RNF216 TMX3 GNPAT FLNC CHERP TCF20 SMPD4 RSBN1 ATP6V1H CSE1L EIF4G1 LRP1 PRKDC RERE | 3.60e-07 | 1203 | 196 | 23 | 29180619 |
| Pubmed | PCNX3 PKD1L1 MECOM SEMA3G DNAH14 HEPH TBC1D9 SYNGAP1 SUN2 HACE1 FAM83G BCAR3 HERC2 PRRC2B CNTN4 CHERP DIDO1 SEC14L6 AP5B1 SERPINE1 USP54 SNRPA DNPEP | 4.28e-07 | 1215 | 196 | 23 | 15146197 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TRIM25 HNRNPH2 DDX1 MDN1 XPO5 TAF1 DDX39B DIDO1 UPF1 CSE1L EIF4G1 PRKDC | 4.66e-07 | 332 | 196 | 12 | 32786267 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.48e-07 | 220 | 196 | 10 | 35785414 | |
| Pubmed | ACACB WDR33 MECOM DDX1 STAU1 KLF5 NFKB1 HELZ TAF1 HERC2 PRRC2B TCF20 DIDO1 UPF1 RSBN1 CSE1L ZFHX4 ACTR6 EIF4G1 LRP6 MRTO4 ELK3 RERE USP54 PCCA | 5.56e-07 | 1429 | 196 | 25 | 35140242 | |
| Pubmed | SF3B4 ACACA ADAR DDX1 STAU1 MDN1 XPO5 DDX39B CHERP UPF1 CSE1L YKT6 EIF4G1 PRKDC LRBA SNRPA | 7.84e-07 | 638 | 196 | 16 | 33239621 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 8.16e-07 | 90 | 196 | 7 | 35654790 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | TRIM25 ACACA ACACB DHX38 ADAR STAU1 DDX39B PRRC2B DIDO1 CSE1L PRKDC PCCA | 1.00e-06 | 357 | 196 | 12 | 37059091 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACA ACACB TSC1 PARVG SYNGAP1 PTPRB MDN1 RIC1 POLR1A U2SURP GAN LIMCH1 LRBA DNPEP | 1.02e-06 | 497 | 196 | 14 | 36774506 |
| Pubmed | SF3B4 ACACA NR1I2 FBXL7 CLPB XPO5 FIG4 CHERP SMPD4 DIDO1 APOB UPF1 MYOF EIF4G1 MRTO4 LIMCH1 SNRPA | 1.50e-06 | 754 | 196 | 17 | 35906200 | |
| Pubmed | 1.75e-06 | 5 | 196 | 3 | 36720308 | ||
| Pubmed | 1.75e-06 | 5 | 196 | 3 | 21983082 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIM25 ACACA DHX38 ADAR DDX1 EIF3CL STAU1 MDN1 CLPB XPO5 MYO18B DDX39B CHERP POLR1A U2SURP APOB UPF1 ATP6V1H CSE1L EIF4G1 MRTO4 PRKDC SNRPA DNPEP | 1.85e-06 | 1425 | 196 | 24 | 30948266 |
| Pubmed | FAM120B TRIM25 SYN3 TSC1 DDX1 EIF3CL STAU1 EHD3 SYNGAP1 DDX39B MTUS2 WNK2 PRRC2B FLNC RAP1GAP OXR1 UPF1 OR52E2 ATP6V1H CSE1L EIF4G1 LIMCH1 USP54 DNPEP | 1.99e-06 | 1431 | 196 | 24 | 37142655 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | WDR33 DDX1 MDN1 TAF1 POLR1A TCF20 U2SURP DIDO1 CSE1L ACTR6 PRKDC SNRPA | 2.78e-06 | 394 | 196 | 12 | 27248496 |
| Pubmed | FAM120B ADAR HNRNPH2 DDX1 STAU1 DDX39B PRRC2B FLNC CHERP U2SURP UPF1 EIF4G1 PRKDC SNRPA | 3.37e-06 | 551 | 196 | 14 | 34728620 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ACACA DHX38 ADAR HNRNPH2 DDX1 STAU1 MDN1 XPO5 UFD1 DDX39B RPF1 FLNC CHERP TCF20 U2SURP DIDO1 MRTO4 PRKDC PCCA | 3.72e-06 | 989 | 196 | 19 | 36424410 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ACACA PCNX3 UBE4B NPHP4 TBC1D9 MDN1 SCN8A HERC2 WNK2 ABCC10 RIC1 PRRC2B ENGASE FLNC MYOF EIF4G1 PCNX1 SENP2 PRKDC LRBA | 4.96e-06 | 1105 | 196 | 20 | 35748872 |
| Pubmed | ACACA STAU1 XPO5 SUN2 HELZ PRRC2B CHERP U2SURP UPF1 SIK3 RSBN1 CSE1L PRKDC RERE USP54 | 5.27e-06 | 655 | 196 | 15 | 35819319 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | ACACB DHX38 NPHP4 PTPRB HERC2 RPF1 MUC16 APOB STIL CSE1L LRP1 PCNX1 | 5.32e-06 | 420 | 196 | 12 | 28065597 |
| Pubmed | 6.07e-06 | 7 | 196 | 3 | 18508616 | ||
| Pubmed | CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women. | 6.07e-06 | 7 | 196 | 3 | 18665040 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SF3B4 WDR33 ADAR DDX1 STAU1 ATAD2B TAF1 DDX39B CHERP TCF20 U2SURP DIDO1 ZDBF2 RSBN1 EIF4G1 PRKDC SNRPA PCCA | 8.66e-06 | 954 | 196 | 18 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDE4C ACACA UBE4B TBC1D9 EIF3CL MDN1 HELZ TCF20 DIDO1 MYOF EIF4G1 ELK3 LIMCH1 PRKDC RERE PARD3 | 9.16e-06 | 774 | 196 | 16 | 15302935 |
| Pubmed | 9.67e-06 | 8 | 196 | 3 | 18728123 | ||
| Pubmed | 9.67e-06 | 8 | 196 | 3 | 21039385 | ||
| Pubmed | 9.67e-06 | 8 | 196 | 3 | 22512338 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | DHX38 MECOM ADAR DDX1 STAU1 MDN1 DDX39B CHERP U2SURP CSE1L ZFHX4 EIF4G1 MRTO4 PRKDC | 9.73e-06 | 605 | 196 | 14 | 28977666 |
| Pubmed | TSC1 EHD3 SYNGAP1 MDN1 PTPRN2 HERC2 UNC79 WNK2 PRRC2B CNTN4 TCF20 DIDO1 UPF1 SIK3 EIF4G1 LRP1 LIMCH1 PARD3 | 9.82e-06 | 963 | 196 | 18 | 28671696 | |
| Pubmed | 1.01e-05 | 241 | 196 | 9 | 23125841 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | FAM120B SF3B4 ACACA ACACB ADAR HNRNPH2 MDN1 DDX39B DIDO1 STIL ATP6V1H CSE1L SNRPA PCCA | 1.37e-05 | 624 | 196 | 14 | 33729478 |
| Pubmed | TRIM25 CLPB DDX39B PRRC2B RPF1 TCF20 U2SURP UPF1 EIF4G1 MRTO4 SNRPA | 2.01e-05 | 403 | 196 | 11 | 35253629 | |
| Pubmed | 2.01e-05 | 263 | 196 | 9 | 34702444 | ||
| Pubmed | 2.08e-05 | 29 | 196 | 4 | 20167577 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 2.14e-05 | 265 | 196 | 9 | 19240061 | |
| Pubmed | FRMPD4 UBE4B TSC1 XPO5 PRRC2B TCF20 RSBN1 DAAM2 SENP2 LIMCH1 RERE | 2.20e-05 | 407 | 196 | 11 | 12693553 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TRIM25 ADAR HNRNPH2 DDX1 STAU1 MDN1 HERC2 DDX39B FLNC CHERP POLR1A TCF20 U2SURP CSE1L EIF4G1 MRTO4 PRKDC SNRPA | 2.22e-05 | 1024 | 196 | 18 | 24711643 |
| Pubmed | TRIM25 DDX1 STAU1 SORT1 MDN1 CLPB XPO5 SUN2 NFKB1 UFD1 TMX3 PRRC2B SMPD4 UPF1 MYOF ATP6V1H CSE1L EIF4G1 SERPINE1 MRTO4 LIMCH1 PRKDC | 2.32e-05 | 1440 | 196 | 22 | 30833792 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.34e-05 | 268 | 196 | 9 | 33024031 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TRIM25 ACACA ACACB DHX38 TSC1 ADAR STAU1 HELZ PRRC2B CHERP U2SURP DIDO1 UPF1 YKT6 PRKDC LRBA PCCA | 2.45e-05 | 934 | 196 | 17 | 33916271 |
| Pubmed | SF3B4 TRIM25 ADAR HNRNPH2 DDX1 DDX39B POLR1A U2SURP UPF1 MYOF EIF4G1 MRTO4 PRKDC SNRPA | 2.55e-05 | 660 | 196 | 14 | 32780723 | |
| Pubmed | 2.78e-05 | 274 | 196 | 9 | 34244482 | ||
| Pubmed | ACACA ACACB MECOM TAF1 TCF20 ZDBF2 ZFHX4 LRP1 RERE LRBA PCCA | 2.81e-05 | 418 | 196 | 11 | 34709266 | |
| Pubmed | Do Gametes Woo? Evidence for Their Nonrandom Union at Fertilization. | 2.81e-05 | 11 | 196 | 3 | 28978771 | |
| Pubmed | 2.85e-05 | 104 | 196 | 6 | 31365120 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 28777242 | ||
| Pubmed | Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity. | 3.16e-05 | 2 | 196 | 2 | 30778091 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 24944901 | ||
| Pubmed | Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. | 3.16e-05 | 2 | 196 | 2 | 22751103 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 15684063 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 23303387 | ||
| Pubmed | Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. | 3.16e-05 | 2 | 196 | 2 | 11114890 | |
| Pubmed | Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. | 3.16e-05 | 2 | 196 | 2 | 20139635 | |
| Pubmed | The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. | 3.16e-05 | 2 | 196 | 2 | 18305370 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 29199543 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 26976583 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 24690595 | ||
| Pubmed | Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. | 3.16e-05 | 2 | 196 | 2 | 16973756 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 22829544 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 17287830 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 15358766 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 33142929 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 23722113 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 31490979 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 23988121 | ||
| Pubmed | IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation. | 3.16e-05 | 2 | 196 | 2 | 35935998 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 17958748 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 10677481 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 30573465 | ||
| Pubmed | Ligand dependent hepatic gene expression profiles of nuclear receptors CAR and PXR. | 3.16e-05 | 2 | 196 | 2 | 22698814 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 34504302 | ||
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 3.16e-05 | 2 | 196 | 2 | 26031789 | |
| Pubmed | De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. | 3.16e-05 | 2 | 196 | 2 | 25282359 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 27693630 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 32215608 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 31581194 | ||
| Pubmed | Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor. | 3.16e-05 | 2 | 196 | 2 | 29772612 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21628639 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 14742670 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 35212371 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 25835148 | ||
| Pubmed | The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression. | 3.16e-05 | 2 | 196 | 2 | 16314510 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 36076520 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 27573304 | ||
| Pubmed | Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. | 3.16e-05 | 2 | 196 | 2 | 24863967 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 30244972 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 28756207 | ||
| Pubmed | CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation. | 3.16e-05 | 2 | 196 | 2 | 29698475 | |
| Interaction | SIRT7 interactions | TRIM25 ACACA DHX38 STAU1 MDN1 XPO5 ATAD2B HELZ HERC2 PRRC2B FLNC CHERP POLR1A TCF20 U2SURP DIDO1 UPF1 CSE1L EIF4G1 MRTO4 PRKDC | 4.67e-06 | 744 | 184 | 21 | int:SIRT7 |
| Interaction | SUMO2 interactions | HDAC9 TRIM25 HNRNPH2 DDX1 MDN1 UBE2H XPO5 RNF216 TAF1 DDX39B DIDO1 UPF1 CSE1L EIF4G1 SENP2 ELK3 PRKDC USPL1 | 8.40e-06 | 591 | 184 | 18 | int:SUMO2 |
| Interaction | BTRC interactions | TRIM25 ACACA ACACB UBE4B DHX38 ADAR DDX1 TBC1D10C MDN1 SUN2 NFKB1 UFD1 RNF128 DDX39B PRRC2B RAP1GAP UPF1 STIL EIF4G1 USP54 FAM219A | 8.71e-06 | 775 | 184 | 21 | int:BTRC |
| Interaction | PRMT1 interactions | FAM120B TRIM25 UBE4B WDR33 MECOM ADAR HNRNPH2 DDX1 STAU1 NR1I2 UBE2H DDX39B PRRC2B FLNC CHERP U2SURP UPF1 EIF4G1 GAN PRKDC SAMD3 SNRPA IGSF21 | 1.37e-05 | 929 | 184 | 23 | int:PRMT1 |
| Interaction | STIP1 interactions | SF3B4 TRIM25 ACACA NPHP4 ADAR DDX1 STAU1 SYNGAP1 FBXL7 MDN1 UBE2H XPO5 UFD1 DDX39B CHERP UPF1 SIK3 STIL CSE1L YKT6 EIF4G1 PRKDC LRBA SNRPA | 1.61e-05 | 1006 | 184 | 24 | int:STIP1 |
| Interaction | MTTP interactions | 2.34e-05 | 19 | 184 | 4 | int:MTTP | |
| Interaction | MIR363 interactions | 3.03e-05 | 97 | 184 | 7 | int:MIR363 | |
| Interaction | FMR1 interactions | TSC1 ADAR DDX1 STAU1 EHD3 SYNGAP1 UBE2H PTPRN2 HERC2 PRRC2B TCF20 UPF1 SIK3 EIF4G1 LRP1 PARD3 | 3.46e-05 | 536 | 184 | 16 | int:FMR1 |
| Interaction | FBXO22 interactions | TRIM25 ACACA ACACB TSC1 PARVG SYNGAP1 PTPRB MDN1 UBE2H RIC1 POLR1A U2SURP GAN LIMCH1 LRBA DNPEP | 3.79e-05 | 540 | 184 | 16 | int:FBXO22 |
| Interaction | AR interactions | TRIM25 WDR33 ADAR HNRNPH2 DDX1 MDN1 XPO5 KLF5 NFKB1 TAF1 PRRC2B CHERP TCF20 U2SURP DIDO1 CSE1L AP5B1 SENP2 LIMCH1 PRKDC RERE USP54 SMAD1 | 3.82e-05 | 992 | 184 | 23 | int:AR |
| Interaction | MS4A4A interactions | 3.89e-05 | 42 | 184 | 5 | int:MS4A4A | |
| Interaction | USP53 interactions | 4.01e-05 | 138 | 184 | 8 | int:USP53 | |
| Interaction | ISG15 interactions | SF3B4 TRIM25 WDR33 DDX1 STAU1 UFD1 DDX39B SIK3 MYOF CSE1L EIF4G1 MRTO4 LIMCH1 PRKDC KLHL26 | 5.06e-05 | 494 | 184 | 15 | int:ISG15 |
| Interaction | ARHGAP32 interactions | 6.90e-05 | 149 | 184 | 8 | int:ARHGAP32 | |
| Interaction | NR2C2 interactions | SF3B4 TRIM25 ACACA ACACB DHX38 ADAR HNRNPH2 DDX1 EIF3CL MDN1 XPO5 HELZ DDX39B CHERP POLR1A U2SURP SMPD4 DIDO1 UPF1 TERT RSBN1 EIF4G1 MRTO4 ELK3 PRKDC LRBA SNRPA PCCA | 7.53e-05 | 1403 | 184 | 28 | int:NR2C2 |
| Interaction | MIR92A1 interactions | 7.95e-05 | 78 | 184 | 6 | int:MIR92A1 | |
| Interaction | EIF3D interactions | TRIM25 MECOM EIF3CL STAU1 UBE2H HERC2 MTUS2 PRRC2B EIF4G1 GAN | 8.55e-05 | 244 | 184 | 10 | int:EIF3D |
| Interaction | YWHAQ interactions | TRIM25 ACACA TSC1 DDX1 GAB2 STAU1 UBE2H CLPB NFKB1 FAM83G UNC79 BICC1 RAP1GAP PARP8 UPF1 SIK3 TERT CSE1L FRMD6 EIF4G1 PRKDC USP54 LRBA PARD3 | 8.60e-05 | 1118 | 184 | 24 | int:YWHAQ |
| Interaction | CPEB4 interactions | 9.52e-05 | 156 | 184 | 8 | int:CPEB4 | |
| Cytoband | 1p36.21 | 1.58e-04 | 63 | 196 | 4 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF25 PRAMEF9 UBE4B NPHP4 RAP1GAP PRAMEF15 PRAMEF4 MRTO4 RERE IGSF21 PRAMEF27 | 1.84e-04 | 681 | 196 | 11 | chr1p36 |
| Cytoband | 5q11.1 | 4.99e-04 | 8 | 196 | 2 | 5q11.1 | |
| GeneFamily | PRAME family | 7.88e-07 | 24 | 134 | 5 | 686 | |
| GeneFamily | SEC14 family|PRELI domain containing | 7.83e-06 | 6 | 134 | 3 | 1063 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.80e-04 | 21 | 134 | 3 | 813 | |
| GeneFamily | Immunoglobulin like domain containing | 5.94e-04 | 193 | 134 | 7 | 594 | |
| GeneFamily | Exportins | 1.12e-03 | 7 | 134 | 2 | 547 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | MECOM DNAH14 CADM1 BICC1 OXR1 FHOD3 SIK3 LIMCH1 MAML2 RERE LRBA PCCA | 4.53e-08 | 208 | 191 | 12 | M39233 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 7.10e-07 | 176 | 191 | 10 | M39223 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MECOM FBXL7 DLC1 MDN1 PTPRK NFKB1 ATAD2B HELZ BCAR3 CHST3 U2SURP SIK3 STIL RSBN1 MYOF ATP6V1H CSE1L SERPINE1 PARD3 PCCA | 4.89e-06 | 856 | 191 | 20 | M4500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | GATM GDPD2 SYNGAP1 NRK RNF128 PCDH18 CNTN4 FLNC MUC16 ZFHX4 ACTR6 LRP1 DAAM2 | 1.12e-05 | 357 | 179 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | GDPD2 SYNGAP1 NRK RNF128 PCDH18 CNTN4 FLNC MUC16 MYOF ZFHX4 ACTR6 LRP1 DAAM2 | 2.68e-05 | 388 | 179 | 13 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | NRK RNF128 PCDH18 CNTN4 FLNC EMB MUC16 ZDBF2 MYOF ZFHX4 ACTR6 LRP1 DAAM2 | 5.76e-05 | 418 | 179 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | GATM GDPD2 SYNGAP1 NRK RNF128 PCDH18 CNTN4 FLNC MUC16 ACTR6 LRP1 DAAM2 | 7.89e-05 | 372 | 179 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 8.12e-05 | 165 | 179 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 8.54e-05 | 28 | 179 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_200 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | ACACA MECOM C8orf34 DNAH14 CADM1 DLC1 PTPRK CNTN4 LRP6 LIMCH1 USP54 PARD3 | 4.87e-11 | 191 | 193 | 12 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | ACACA MECOM C8orf34 DNAH14 CADM1 DLC1 PTPRK KLF5 CNTN4 LIMCH1 USP54 PARD3 | 5.18e-11 | 192 | 193 | 12 | 499e8893afea5e6d3371e0bd018f7e86a524d669 |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | ACACA MECOM C8orf34 DNAH14 CADM1 DLC1 PTPRK CNTN4 LRP6 LIMCH1 USP54 PARD3 | 5.18e-11 | 192 | 193 | 12 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | ACACA MECOM GAB2 CADM1 PTPRK SIK3 LIMCH1 MAML2 RERE LRBA PARD3 PCCA | 7.41e-11 | 198 | 193 | 12 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | ACACA MECOM C8orf34 CADM1 PTPRK KLF5 CNTN4 MACC1 LIMCH1 USP54 LRBA | 6.40e-10 | 187 | 193 | 11 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | MECOM C8orf34 DNAH14 CADM1 DLC1 PTPRK CNTN4 MACC1 LIMCH1 USP54 PARD3 | 8.01e-10 | 191 | 193 | 11 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ACACA MECOM C8orf34 DNAH14 CADM1 DLC1 PTPRK LIMCH1 USP54 LRBA PARD3 | 9.98e-10 | 195 | 193 | 11 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | ACACA MECOM CADM1 PTPRK SIK3 LIMCH1 MAML2 RERE LRBA PARD3 PCCA | 1.05e-09 | 196 | 193 | 11 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | Control|World / group, cell type (main and fine annotations) | MECOM C8orf34 CADM1 DLC1 PTPRK PTPRN2 CNTN4 LIMCH1 USP54 PARD3 | 3.49e-09 | 168 | 193 | 10 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | CYP2A7 ACACA MECOM C8orf34 CADM1 PTPRK CNTN4 LIMCH1 USP54 PARD3 | 6.09e-09 | 178 | 193 | 10 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | CYP2A7 MECOM C8orf34 PTPRK CNTN4 MACC1 LGSN LIMCH1 USP54 PARD3 | 7.14e-09 | 181 | 193 | 10 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | ACACA MECOM C8orf34 CADM1 PTPRK CNTN4 LRP6 LIMCH1 USP54 PARD3 | 8.81e-09 | 185 | 193 | 10 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MECOM C8orf34 DNAH14 CADM1 PTPRK KLF5 CNTN4 MACC1 USP54 LRBA | 9.27e-09 | 186 | 193 | 10 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | PDE4C C8orf34 CADM1 DLC1 PTPRK KLF5 RAP1GAP LIMCH1 USP54 PARD3 | 1.03e-08 | 188 | 193 | 10 | eb6d79d733b53f64ca615bb777c64ed456866549 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-08 | 192 | 193 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MECOM DNAH14 CADM1 PTPRK KLF5 SEMA3B MACC1 LIMCH1 USP54 PARD3 | 1.32e-08 | 193 | 193 | 10 | a0ca3231992f14abcf1a6129573bace320e89d2a |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-08 | 195 | 193 | 10 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-08 | 196 | 193 | 10 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ACACA MECOM C8orf34 DNAH14 CADM1 PTPRK LRP6 LIMCH1 USP54 PARD3 | 1.77e-08 | 199 | 193 | 10 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ACACA MECOM C8orf34 DNAH14 CADM1 DLC1 PTPRK LIMCH1 USP54 PARD3 | 1.77e-08 | 199 | 193 | 10 | 8587bd98de7767a575088afbea07a1feb4516b9b |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.93e-08 | 170 | 193 | 9 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.23e-08 | 179 | 193 | 9 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-07 | 182 | 193 | 9 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-07 | 182 | 193 | 9 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.11e-07 | 183 | 193 | 9 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.22e-07 | 185 | 193 | 9 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.40e-07 | 188 | 193 | 9 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.40e-07 | 188 | 193 | 9 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-07 | 189 | 193 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-07 | 190 | 193 | 9 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-07 | 191 | 193 | 9 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.68e-07 | 192 | 193 | 9 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.75e-07 | 193 | 193 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 194 | 193 | 9 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-07 | 194 | 193 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 194 | 193 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 196 | 193 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-07 | 199 | 193 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-07 | 199 | 193 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-07 | 199 | 193 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.27e-07 | 199 | 193 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 2.37e-07 | 200 | 193 | 9 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-06 | 179 | 193 | 8 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-06 | 183 | 193 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 183 | 193 | 8 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 183 | 193 | 8 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-06 | 184 | 193 | 8 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.51e-06 | 185 | 193 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.58e-06 | 186 | 193 | 8 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 188 | 193 | 8 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 188 | 193 | 8 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 188 | 193 | 8 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.71e-06 | 188 | 193 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 188 | 193 | 8 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 188 | 193 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-06 | 189 | 193 | 8 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 190 | 193 | 8 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-06 | 190 | 193 | 8 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 190 | 193 | 8 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-06 | 191 | 193 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 191 | 193 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-06 | 191 | 193 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 192 | 193 | 8 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-06 | 193 | 193 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-06 | 193 | 193 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 194 | 193 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 194 | 193 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 194 | 193 | 8 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 194 | 193 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 2.24e-06 | 195 | 193 | 8 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 2.33e-06 | 196 | 193 | 8 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-06 | 197 | 193 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-06 | 197 | 193 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-06 | 197 | 193 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 147 | 193 | 7 | a5ed71afe5fcb4f541080f5552252695c7d4d090 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 158 | 193 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 158 | 193 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-06 | 164 | 193 | 7 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-06 | 164 | 193 | 7 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-06 | 164 | 193 | 7 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.55e-06 | 170 | 193 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.55e-06 | 170 | 193 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 1.11e-05 | 174 | 193 | 7 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 176 | 193 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 176 | 193 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 176 | 193 | 7 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 176 | 193 | 7 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.29e-05 | 178 | 193 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 178 | 193 | 7 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 178 | 193 | 7 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.34e-05 | 179 | 193 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 179 | 193 | 7 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.38e-05 | 180 | 193 | 7 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.43e-05 | 181 | 193 | 7 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-05 | 181 | 193 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 181 | 193 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 183 | 193 | 7 | 876b4f128c2168fdae7488201ff44f19c06c8415 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 183 | 193 | 7 | b190b650e61b1b20baf5e42d04acac82d3fd1400 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 183 | 193 | 7 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| Disease | age at menarche | FAM120B NXPE2 GAB2 CADM1 PTPRK PTPRN2 HACE1 UNC79 SLC27A5 ZFHX4 EIF4G1 GAN UNC13C RERE | 2.52e-05 | 594 | 185 | 14 | EFO_0004703 |
| Disease | cell adhesion molecule 1 measurement | 3.91e-05 | 2 | 185 | 2 | EFO_0020251 | |
| Disease | Colorectal Carcinoma | ABCA4 ACACA OTOP2 C8orf34 DLC1 PTPRN2 KLF5 CNTN4 FLNC PARP8 APOB CSE1L EIF4G1 LRP1 IGSF21 | 3.98e-05 | 702 | 185 | 15 | C0009402 |
| Disease | fatty liver disease (implicated_via_orthology) | 4.12e-05 | 31 | 185 | 4 | DOID:9452 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | ABCA4 SYN3 MYOC OTOP2 MECOM GAB2 DLC1 KLF5 HERC2 BICC1 MYOF DAAM2 | 9.62e-05 | 509 | 185 | 12 | EFO_0004695 |
| Disease | COVID-19 symptoms measurement, COVID-19 | 1.17e-04 | 3 | 185 | 2 | EFO_0600019, MONDO_0100096 | |
| Disease | amygdala volume change measurement | 1.28e-04 | 16 | 185 | 3 | EFO_0021490 | |
| Disease | uric acid measurement | SYN3 PCNX3 MECOM DDX1 NFKB1 BICC1 SLC27A5 PRRC2B CNTN4 POLR1A MYOF UNC5CL SENP2 | 1.35e-04 | 610 | 185 | 13 | EFO_0004761 |
| Disease | coronary artery disease | HDAC9 SYN3 PCNX3 WDR33 CETP DHX38 MECOM C8orf34 DLC1 PCDH18 BICC1 WNK2 ABCC10 CHST3 EMB PARP8 APOB RSBN1 LRP1 | 1.95e-04 | 1194 | 185 | 19 | EFO_0001645 |
| Disease | syndromic X-linked intellectual disability (is_implicated_in) | 2.33e-04 | 4 | 185 | 2 | DOID:0060309 (is_implicated_in) | |
| Disease | mean platelet volume | HDAC9 AOC1 PCNX3 MECOM EHD3 ATAD2B DDX39B FBXO34 PCDHGA7 U2SURP SIK3 STIL TERT RSBN1 PCDHGA12 MAML2 PCDHGA8 | 2.51e-04 | 1020 | 185 | 17 | EFO_0004584 |
| Disease | amino acid measurement | ACACB CYP2J2 NXPE2 CADM1 PTPRB PTPRN2 SUN2 MTUS2 WNK2 GAN UNC13C PRKDC LRBA | 3.73e-04 | 678 | 185 | 13 | EFO_0005134 |
| Disease | pulse pressure measurement, unipolar depression | 3.86e-04 | 5 | 185 | 2 | EFO_0003761, EFO_0005763 | |
| Disease | migraine disorder, type 1 diabetes mellitus | 3.86e-04 | 5 | 185 | 2 | MONDO_0005147, MONDO_0005277 | |
| Disease | muscular disease (implicated_via_orthology) | 3.86e-04 | 5 | 185 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in large LDL percentage | 4.26e-04 | 56 | 185 | 4 | EFO_0022235 | |
| Disease | urate measurement | PDE4C PCNX3 DHX38 MECOM DDX1 MYO18B BICC1 FBXO34 PRRC2B U2SURP SEC14L3 UNC5CL AP5B1 LRP1 SENP2 | 5.50e-04 | 895 | 185 | 15 | EFO_0004531 |
| Disease | diabetes mellitus (implicated_via_orthology) | 5.67e-04 | 26 | 185 | 3 | DOID:9351 (implicated_via_orthology) | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 5.77e-04 | 6 | 185 | 2 | DOID:13809 (is_marker_for) | |
| Disease | alkaline phosphatase measurement | CYP2A7 PDE4C AOC1 ACACB DHX38 ABCC10 RIC1 MACC1 RAP1GAP U2SURP APOB RSBN1 YKT6 UNC13C LRBA SNRPA | 6.97e-04 | 1015 | 185 | 16 | EFO_0004533 |
| Disease | response to angiotensin receptor blocker | 8.69e-04 | 30 | 185 | 3 | EFO_0010735 | |
| Disease | basophil percentage of leukocytes | 8.94e-04 | 243 | 185 | 7 | EFO_0007992 | |
| Disease | apolipoprotein A 1 measurement | CYP2A7 AOC1 ACACB CETP DHX38 ADAR NR1I2 DLC1 UGT2B10 OR8J2 APOB SIK3 SEC14L6 LRP1 | 9.71e-04 | 848 | 185 | 14 | EFO_0004614 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.05e-03 | 71 | 185 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | phenol sulfate measurement | 1.07e-03 | 8 | 185 | 2 | EFO_0021011 | |
| Disease | Lymphoid leukemia | 1.07e-03 | 8 | 185 | 2 | C0023448 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.26e-03 | 34 | 185 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | ureteral obstruction (implicated_via_orthology) | 1.37e-03 | 9 | 185 | 2 | DOID:5199 (implicated_via_orthology) | |
| Disease | Thyroid Gland Follicular Adenoma | 1.37e-03 | 35 | 185 | 3 | C0151468 | |
| Disease | Cardiovascular Diseases | 1.49e-03 | 36 | 185 | 3 | C0007222 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.49e-03 | 36 | 185 | 3 | EFO_0022257 | |
| Disease | colorectal cancer | C8orf34 PTPRN2 KLF5 HERC2 BICC1 SLC27A5 CHST3 TERT LRP1 PCNX1 LRBA | 1.58e-03 | 604 | 185 | 11 | MONDO_0005575 |
| Disease | ovarian neoplasm | 1.60e-03 | 134 | 185 | 5 | C0919267 | |
| Disease | Thyroid Neoplasm | 1.61e-03 | 37 | 185 | 3 | C0040136 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.61e-03 | 37 | 185 | 3 | EFO_0022252 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.70e-03 | 10 | 185 | 2 | OBA_2045163 | |
| Disease | abdominal aortic calcification measurement | 1.70e-03 | 10 | 185 | 2 | EFO_0010272 | |
| Disease | Malignant neoplasm of ovary | 1.76e-03 | 137 | 185 | 5 | C1140680 | |
| Disease | cortical thickness | HDAC9 ABCA4 MECOM STAU1 FBXL7 DLC1 CDH20 XPO5 NFKB1 WNK2 ABCC10 LRP1 RERE PARD3 PCCA ANKFN1 | 1.81e-03 | 1113 | 185 | 16 | EFO_0004840 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.87e-03 | 139 | 185 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Parkinson disease, disease progression measurement | 1.88e-03 | 39 | 185 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | lobe attachment | 2.01e-03 | 207 | 185 | 6 | EFO_0007667 | |
| Disease | anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine | 2.07e-03 | 11 | 185 | 2 | EFO_0803358, EFO_0803362 | |
| Disease | triacylglycerol 56:2 measurement | 2.07e-03 | 11 | 185 | 2 | EFO_0010429 | |
| Disease | beta thalassemia (is_marker_for) | 2.07e-03 | 11 | 185 | 2 | DOID:12241 (is_marker_for) | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 2.07e-03 | 11 | 185 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 2.07e-03 | 11 | 185 | 2 | OBA_2045170 | |
| Disease | blood urea nitrogen measurement | 2.31e-03 | 452 | 185 | 9 | EFO_0004741 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 2.33e-03 | 42 | 185 | 3 | EFO_0022255 | |
| Disease | integral membrane protein 2B measurement | 2.48e-03 | 12 | 185 | 2 | EFO_0802634 | |
| Disease | Myeloproliferative disease | 2.48e-03 | 12 | 185 | 2 | C0027022 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 2.49e-03 | 43 | 185 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.49e-03 | 43 | 185 | 3 | EFO_0022290 | |
| Disease | immunoglobulin isotype switching measurement | 2.66e-03 | 44 | 185 | 3 | EFO_0010128 | |
| Disease | Thyroid carcinoma | 2.66e-03 | 44 | 185 | 3 | C0549473 | |
| Disease | smoking status measurement | ADAR GAB2 SYNGAP1 DLC1 PTPRK PTPRN2 HACE1 UNC79 PRRC2B CNTN4 POLR1A TCF20 SERPINE1 RERE PCCA IGSF21 | 2.72e-03 | 1160 | 185 | 16 | EFO_0006527 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.76e-03 | 152 | 185 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Common variable immunodeficiency | 2.91e-03 | 13 | 185 | 2 | cv:C0009447 | |
| Disease | complement component C6 measurement | 2.91e-03 | 13 | 185 | 2 | EFO_0020281 | |
| Disease | Hyperlipoproteinemia Type IIb | 2.91e-03 | 13 | 185 | 2 | C1704417 | |
| Disease | triacylglycerol 54:4 measurement | 3.02e-03 | 46 | 185 | 3 | EFO_0010422 | |
| Disease | Adenocarcinoma of large intestine | 3.17e-03 | 96 | 185 | 4 | C1319315 | |
| Disease | Neuroblastoma | 3.21e-03 | 47 | 185 | 3 | C0027819 | |
| Disease | Malignant neoplasm of breast | ABCA4 MAN2C1 MECOM ADAR CADM1 CDH20 BCAR3 HERC2 RAP1GAP SIK3 TERT SLC5A5 ELK3 USP54 LRBA | 3.28e-03 | 1074 | 185 | 15 | C0006142 |
| Disease | lymphocyte percentage of leukocytes | 3.31e-03 | 665 | 185 | 11 | EFO_0007993 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.39e-03 | 14 | 185 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | phoneme awareness | 3.39e-03 | 14 | 185 | 2 | EFO_0021812 | |
| Disease | schizophrenia, anorexia nervosa | 3.41e-03 | 48 | 185 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | total lipids in lipoprotein particles measurement | 3.41e-03 | 48 | 185 | 3 | EFO_0022309 | |
| Disease | ceramide measurement | 3.77e-03 | 235 | 185 | 6 | EFO_0010222 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 3.83e-03 | 50 | 185 | 3 | EFO_0022334 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 3.83e-03 | 50 | 185 | 3 | EFO_0022303 | |
| Disease | mouth morphology measurement | 3.83e-03 | 50 | 185 | 3 | EFO_0007955 | |
| Disease | Proteinuria | 3.89e-03 | 15 | 185 | 2 | HP_0000093 | |
| Disease | triacylglycerol 52:3 measurement | 3.89e-03 | 15 | 185 | 2 | EFO_0010415 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 3.89e-03 | 15 | 185 | 2 | EFO_0022328 | |
| Disease | Hypertriglyceridemia | 3.89e-03 | 15 | 185 | 2 | C0020557 | |
| Disease | chronotype measurement | NXPE2 SYNGAP1 CADM1 FIG4 KLF5 ATAD2B SCN8A BICC1 ABCC10 CNTN4 TCF20 RERE ANKFN1 | 3.89e-03 | 882 | 185 | 13 | EFO_0008328 |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 4.05e-03 | 51 | 185 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | phospholipids in very small VLDL measurement | 4.05e-03 | 51 | 185 | 3 | EFO_0022300 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 4.05e-03 | 51 | 185 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 4.05e-03 | 51 | 185 | 3 | EFO_0022240 | |
| Disease | creatinine measurement | GATM MECOM DDX1 GAB2 DLC1 CDH20 NFKB1 BCAR3 RNF128 ABCC10 AP5B1 SENP2 PARD3 IGSF21 | 4.18e-03 | 995 | 185 | 14 | EFO_0004518 |
| Disease | basophil count, eosinophil count | 4.26e-03 | 241 | 185 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | ovarian carcinoma | 4.28e-03 | 321 | 185 | 7 | EFO_0001075 | |
| Disease | phospholipids in medium VLDL measurement | 4.28e-03 | 52 | 185 | 3 | EFO_0022154 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 4.28e-03 | 52 | 185 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | Hyperlipoproteinemia Type IIa | 4.43e-03 | 16 | 185 | 2 | C0745103 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 4.43e-03 | 16 | 185 | 2 | EFO_0004792, HP_0002140 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.43e-03 | 16 | 185 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | triglycerides in HDL measurement | 4.51e-03 | 53 | 185 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 4.51e-03 | 53 | 185 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 4.51e-03 | 53 | 185 | 3 | EFO_0022258 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.52e-03 | 106 | 185 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | total lipids in medium VLDL | 4.76e-03 | 54 | 185 | 3 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 4.76e-03 | 54 | 185 | 3 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 4.76e-03 | 54 | 185 | 3 | EFO_0022244 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 4.83e-03 | 108 | 185 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | melanoma | 4.89e-03 | 248 | 185 | 6 | C0025202 | |
| Disease | Lipidemias | 5.00e-03 | 17 | 185 | 2 | C1706412 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIQNLPEEMQPHFFK | 301 | Q9GZN1 | |
| VMVKFLFPRPDQQHS | 361 | P11597 | |
| MFLLTSPQYHPLPQD | 566 | Q9N2K0 | |
| NENFGPNTEMHLVPI | 186 | Q9ULA0 | |
| LIHMDQNFGNRPVTP | 101 | P51589 | |
| QNFGNRPVTPMREHI | 106 | P51589 | |
| SPRIQEFIHRPSMQD | 281 | P78363 | |
| FASLPRNMPVNHQFP | 6 | O75815 | |
| NFPAIAIHRGMPQEE | 311 | Q13838 | |
| VLIIFHNPSLRAPMF | 66 | P47775 | |
| QQLLEPQQYMAFLPH | 566 | Q9NWN3 | |
| PMASHPQTRIQAYLE | 86 | Q49A92 | |
| PDNHSPITMYVIQAR | 621 | Q8IWV2 | |
| NHIFLNFVPTVIMDP | 1471 | Q13085 | |
| MPTGVPLRRHFNSNF | 421 | P19801 | |
| NNFPVLAANSFRAMP | 61 | O15335 | |
| MQRTGAQIHFPDPSN | 311 | Q9H694 | |
| PQMLRLNADPHFFTQ | 306 | Q13319 | |
| GMQNSLPRNFFLHPV | 1346 | Q96F81 | |
| PGHPFSQMSEKFLQE | 721 | Q5JR59 | |
| SHLIFPQPNYVDMLI | 766 | Q9Y5G6 | |
| FYLTPNSPAEMLHNV | 261 | Q9HBI0 | |
| QVLQEVSMSRYIPHP | 626 | Q4ADV7 | |
| SHLIFPQPNYADMLI | 766 | Q9Y5G5 | |
| SHLIFPQPNYADMLV | 766 | O60330 | |
| IMDHDPRNPAYIATQ | 806 | Q92932 | |
| SMLHQGQYQPRPSFR | 836 | Q9HCL0 | |
| SPGFLFHPQMSAIEN | 851 | Q03112 | |
| VEFQFMLPSSHPNRM | 1321 | O00763 | |
| GTMFEQFVQFRPPAH | 126 | Q14994 | |
| HPLQFMEFSSPIPNA | 31 | Q86T65 | |
| MFLPNDTQFHPSSFL | 1 | Q8NGJ4 | |
| FLGPSMARQPNILVH | 3056 | Q8WXI7 | |
| HRVLMAPVTFFNATP | 1006 | Q5T3U5 | |
| IQLLFNDMKVFPPFH | 851 | P23467 | |
| NDMKVFPPFHLVNTA | 856 | P23467 | |
| FVYTRPHPNSQMDKF | 256 | O95013 | |
| PVNRQLKFMHTPHQF | 656 | Q8N3A8 | |
| PFHNFSMVNSLIYPR | 401 | A8MTJ6 | |
| QEIHSRLMGPQAYPV | 4261 | Q9NU22 | |
| FKDPNPMHIDATFNI | 296 | P50440 | |
| VAFNVNNLPFTEPML | 2266 | O95714 | |
| QPFDLQVYHPSRQPM | 1521 | Q07954 | |
| FFQELILNQASMAPP | 906 | Q9ULI0 | |
| QPHTNENREIMKPFF | 3346 | Q5CZC0 | |
| FEIPPHMKNQALFPA | 216 | Q92499 | |
| YNFFSPLNPMRVHIE | 306 | P55795 | |
| AQPFAVPHSAMLFIQ | 1476 | Q96RV3 | |
| PFAVPHSAMLFVQAL | 1266 | Q9H6A9 | |
| SAPPFVHIIMANVFL | 281 | Q8NH61 | |
| IMQAPVPHSQRRESF | 106 | Q08493 | |
| DRFQVPTAHSEMQPL | 6 | Q8IW50 | |
| FHPRPNFRQMKLENV | 86 | Q14315 | |
| QINAFLQGFHMFIPP | 756 | Q8IYU2 | |
| LQGFHMFIPPSLIQL | 761 | Q8IYU2 | |
| QFMQGYPSKVHILPR | 306 | Q99972 | |
| PILTQFTPYLGHMRN | 221 | P0DUQ1 | |
| EHPNSMIPAFDQRNG | 706 | P50851 | |
| FSPMDIHAFSQQRQP | 266 | O75581 | |
| SIMFDLRRPPQNHTY | 351 | Q9HCC8 | |
| AQLYQARPMLAPHFV | 491 | Q2VPB7 | |
| DIHPFATPLMQELFG | 416 | O75469 | |
| QHFQENSRMPVIKPD | 541 | P05165 | |
| NYSVLQHLGQFPPLM | 1856 | P42694 | |
| PEMVGHPAFAVIFQL | 346 | O75161 | |
| IFNSPLEAAMAFPHL | 31 | Q9NXE4 | |
| LEAAMAFPHLQQPSF | 36 | Q9NXE4 | |
| TDSRLQTPMYFFPQH | 51 | Q8NH89 | |
| FHSVFNPMLNPLIYS | 276 | Q6IF42 | |
| IDPQLHTPMYFLLSQ | 51 | Q8NHA4 | |
| FQNMFIIESLHRGPP | 416 | Q7RTS6 | |
| VDPQLQTPMYFFLRH | 51 | Q8NGG1 | |
| DLSRSFINNPHPAME | 536 | Q8IZL2 | |
| GVLLVTPNNIMFDPH | 231 | Q8N573 | |
| VQYRMHPALSAFPSN | 711 | Q92900 | |
| EMPQHAVLSGPNLFI | 286 | Q9BY67 | |
| DQFGPPMIIHFRVQY | 101 | Q96NE9 | |
| HADPPVQILYNRTMV | 601 | B5ME19 | |
| FNLQNMGLPDFHIPE | 1261 | P04114 | |
| VYSGPHPQREMLTAQ | 161 | Q9BYI3 | |
| ILVHGFQNEVFPEPM | 361 | Q96ID5 | |
| HFMPPELLQSQFETL | 141 | Q5T6J7 | |
| NYQVLPFRQHEMQSP | 286 | Q53HC5 | |
| FNMIEQSGPPHEPRF | 521 | P55265 | |
| PRYIPQKQSEDMHAF | 351 | O15228 | |
| PHNFNRFPPRFMQDD | 541 | Q8IWX8 | |
| RLPDHSMVQIFSFLP | 116 | Q9UJT9 | |
| NMIYIPNDSVRVTHP | 131 | Q92562 | |
| ANPHLEMRFLNLGPF | 356 | Q9HBT6 | |
| PNSPQDFIDSFLIHM | 261 | P20853 | |
| FINHMTQAIPFDDPR | 51 | Q14CM0 | |
| NVLRFHFMSPPPAQS | 441 | Q9H5Z1 | |
| ALPPMNEARHNFGIV | 356 | Q9H2C0 | |
| FMGHPPYAIREVNIN | 1226 | Q2V2M9 | |
| PSRFHFQGQAPQVMK | 2006 | Q9BTC0 | |
| RTLIFPPSMHFFQAK | 76 | Q9NZK5 | |
| NPHFLPSVYNFVTMI | 2591 | Q0VDD8 | |
| STLFQFPTLLNGHMP | 371 | P41970 | |
| QFIFASMQKPEGLPH | 621 | Q04637 | |
| FQEVSLRAFLDPPHM | 246 | Q6ZN28 | |
| PDTFGYSAQLPQIMH | 371 | Q9NTJ4 | |
| NPLQRNEMGHTPLDY | 291 | Q9H078 | |
| GNMPPFLRYLTTQLH | 246 | Q8NFI3 | |
| FTSPPLREEIMANNF | 41 | Q6PCB8 | |
| FMQQPFLEPTHTRAL | 571 | Q9UKV0 | |
| VLPSQRYNAHMVPED | 336 | Q9UDX4 | |
| VLPSQRYNAHMVPED | 336 | Q9UDX3 | |
| VLPSQRYNAHMVPED | 336 | B5MCN3 | |
| HPPVAILARNSDNFM | 276 | Q8TDX9 | |
| NTIPFRNVMTALQFP | 201 | Q8NG08 | |
| NHIRASVYPPAANME | 71 | Q9H3Y0 | |
| SHKEQPGRNMFFIPS | 121 | Q96EK7 | |
| TFPFLDKMPEANQLH | 726 | Q9UPQ0 | |
| FPALTFLNNHDQPFM | 226 | Q5TDP6 | |
| PLEQFPHSMEPQLRQ | 141 | Q9UKD2 | |
| PLSITFMDQHNFSPR | 816 | Q15262 | |
| FHPRELNAEPSQMQI | 551 | Q8TEW0 | |
| FDPSMLLQRFSVAPH | 286 | Q86T96 | |
| IMDRPFLFVVRHNPT | 376 | P05121 | |
| RPFFSSNPELDNLMI | 36 | A6NDR6 | |
| FVYTRPHPNSQMDKF | 256 | Q6IEY1 | |
| RASVYMQPPIDGQAH | 146 | A6ND36 | |
| RPTSANMLQHPFVRD | 301 | Q7Z2Y5 | |
| QPTLFTFEPPVSNHM | 166 | Q9UQC2 | |
| EYRVPQGVQTPFMTH | 326 | Q5VWQ0 | |
| VEQTFFPNHKPMVTA | 226 | O14994 | |
| RDKPITFTQHQMPLF | 561 | Q9HC62 | |
| NFVQTDLPFHPLTQM | 206 | Q99523 | |
| FLPMLNRQDPFTVHM | 126 | Q9UI12 | |
| MPFGLHRQFPENSLQ | 881 | O95602 | |
| PATFINMYNRPIHIT | 226 | Q8TBZ9 | |
| HPPDYVIQNQIGMFL | 541 | Q96DL1 | |
| RHGEQMPSFYPAENL | 101 | Q8N6K7 | |
| MRDLPNTYPFHTPVN | 1396 | P21675 | |
| QISPQLHTPMYFFLS | 66 | P0C617 | |
| VFYNRASQPFSMQPH | 471 | Q9BQS7 | |
| PILTQFTPYLGHMRN | 221 | A6NGN4 | |
| LQLHLPMNFTSYIVP | 176 | A8MTI9 | |
| FNFPGTRNEVIPMSH | 146 | Q8TEB7 | |
| NTPFVPDMIASNFLH | 301 | P47736 | |
| QAPFLQVAPNVNFMH | 496 | Q9Y2K2 | |
| KNIFHMFPVSQPFVD | 166 | P61647 | |
| PILTQFTPYLGHMRN | 221 | A3QJZ7 | |
| NVRVNYDFGPIHMPL | 836 | Q9NWF9 | |
| SDPLARLQMFNVTPH | 1411 | Q9P2R6 | |
| MSIPFSNTHYRIPQG | 1 | Q15506 | |
| QNSMAPHPARDYVVL | 1416 | Q96QB1 | |
| HQISPGDFPNLKRMQ | 346 | Q9NZN3 | |
| FRNLGQNEPHMPLNA | 156 | Q15797 | |
| PLEQATQFSAFLLPM | 531 | Q9UPE1 | |
| NPMFRFLFENQTPAH | 456 | O15042 | |
| TPHSGFLNLPLQMFE | 741 | Q8N957 | |
| FITPLPEDHLTQFMF | 206 | Q7LGC8 | |
| HLSRYQNPREADPMT | 126 | O15498 | |
| GALIRPLPSQQMFEH | 131 | Q96JJ7 | |
| PILTQFTPYLGHMRN | 221 | O60810 | |
| RMFASLFPHNPQFIG | 261 | Q9H9Y2 | |
| QMNTRFPSSRMVPFH | 11 | Q15468 | |
| HFPMTPEALLQFQQP | 1676 | Q86UP3 | |
| PIFMLHFVEGLPQND | 416 | Q5W0Q7 | |
| PMIPQSGKQHLLDFF | 141 | Q92574 | |
| QGFYLLNSIIEHMPP | 746 | P55060 | |
| PSIGFMNKIFHPNID | 66 | P62256 | |
| QALIYPMSSTIPHNF | 1086 | Q8NB66 | |
| MPHSFANLPLRFGRN | 81 | Q9HCQ7 | |
| GEPIQTFHFQAPTMA | 671 | Q9UH99 | |
| DEFRMPYLSHQQLPA | 401 | O95793 | |
| LRIPLSFQNPLFHMA | 921 | Q96PV0 | |
| HSRINLMDFNPDPRS | 226 | Q92911 | |
| PAYATPHFIRIQDAM | 621 | Q9Y2P5 | |
| ISMNLVPFPQLHYLV | 286 | Q9UJT0 | |
| FARNHPLMYNSVLPT | 401 | Q13214 | |
| RQFPLHEMFVSPQGH | 141 | Q8IV04 | |
| PILTQFTPYLGHMRN | 221 | P0DUQ2 | |
| QPRTQKFFEMIENHP | 946 | O95155 | |
| VAEMPQNYRPHPQRF | 481 | Q14258 | |
| RSLPEHPAFQNEMGI | 566 | Q6ZT07 | |
| PQNDLLGHPMTRAFI | 356 | P22309 | |
| RQHLPATLPEMVAFY | 66 | Q8IV45 | |
| PLMAVPARYGFNSHQ | 2106 | Q9HCK1 | |
| PQLVLPNFDMLYNHV | 616 | Q9HAV4 | |
| LQPFRSQVYMHPSLS | 1991 | Q5JSZ5 | |
| PMTPQFEHVLAVGNL | 776 | Q9UQD0 | |
| RVPQAAQLHSVAMPF | 731 | Q4G0T1 | |
| LGVQDLLQFHFMDPP | 901 | Q92620 | |
| EVPVRSPMQFHQNFS | 351 | Q9UGU0 | |
| IMVVDSPGFQNPRHQ | 941 | Q8IUG5 | |
| QLIVAHFPMQSREFP | 1716 | P78527 | |
| NFAHRFPPASVKMLQ | 111 | Q8TCE9 | |
| MFDHPIPRVFQNRFS | 6 | Q92890 | |
| GIPLFFDQPDNIAHM | 391 | P36537 | |
| AVGHLPFQPDMVSQL | 61 | Q86WZ6 | |
| PDEVLQFARAHPLMF | 401 | Q9NS98 | |
| FFHMPRFQHQAPRQL | 11 | Q9C0J8 | |
| QQHFPDPAMSFAPVL | 696 | Q9Y3S1 | |
| MAVPETRPNHTIYIN | 1 | P09012 | |
| ELFLQAGPVVNTHMP | 31 | Q15427 | |
| PYMRQFVAHLQETSP | 771 | O14746 | |
| FNPHPSRFMDLDELQ | 771 | Q70EL1 | |
| RRVQHNMLSPFHSPF | 746 | Q9P2D8 | |
| PYSINMNVFLPDITH | 131 | Q13887 | |
| DHYIPNTLNPVFGRM | 1591 | Q9NZM1 | |
| LTHTIFNPEVFQPQM | 21 | P19838 |